Financial Agenda 2018
Financial Agenda 2018
Onxeo Announces its Financial Agenda for 2018
Paris (France), January 23, 2018 – 5:45 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO - FR0010095596), (“Onxeo” or the “Company”), a biotechnology company specializing in the development of innovative drugs in oncology, in particular against rare or resistant cancers, today announced its financial agenda for 2018.
|
Event |
Date* |
|
Full-year 2017 results |
Thursday, March 29, 2018 |
|
Q1 2018 financial information |
Friday, May 4, 2018 |
|
Shareholders’ general meeting |
Wednesday, May 16, 2018 |
|
Half-year 2018 results |
Friday, July 27, 2018 |
|
Q3 2018 financial information |
Thursday, October 25, 2018 |
* This preliminary agenda may be modified. Press releases are published after financial markets close.